<- Go Home
Devyser Diagnostics AB (publ)
Devyser Diagnostics AB (publ) provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa. It offers kits and reagents, such as post-transplantation, thalassemia, fetal RHD screening NIPT, Cystic fibrosis cardiovascular diseases, male infertility, rapid aneuploidy analysis, accessories, hereditary cancer, and transfusion medicine products; and Amplicon Suite and Advyser for cloud-based software solutions for data analysis and the interpretation of test results. The company was incorporated in 2004 and is headquartered in Årsta, Sweden.
Market Cap
SEK 1.1B
Volume
28.9K
Cash and Equivalents
SEK 75.3M
EBITDA
SEK 43.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
SEK 206.7M
Profit Margin
80.27%
52 Week High
SEK 159.60
52 Week Low
SEK 57.80
Dividend
N/A
Price / Book Value
2.93
Price / Earnings
70.41
Price / Tangible Book Value
3.06
Enterprise Value
SEK 1.0B
Enterprise Value / EBITDA
18.35
Operating Income
SEK 34.8M
Return on Equity
4.36%
Return on Assets
4.71
Cash and Short Term Investments
SEK 75.3M
Debt
SEK 49.0M
Equity
SEK 357.9M
Revenue
SEK 257.5M
Unlevered FCF
-SEK 35.0M
Sector
Biotechnology
Category
N/A